Loading…
Reported covered position: Assistant Secretary for Legislation - HHS
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Pharmacy and Medically Underserved Areas Enhancement Act
Client: PAPCC COALITION · Firm: LEAVITT PARTNERS, LLC
S.109/H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act
Pharmacy and Medically Underserved Areas Enhancement Act
Client: PAPCC COALITION · Firm: LEAVITT PARTNERS, LLC
S.109/H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PHARMACEUTICAL DISTRIBUTION SECURITY ALLIANCE (PDSA) via LEAVITT PARTNERS, LLC
2022 · first_quarter · 1A
Pharmaceutical distribution and supply chain security.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
THE DUAL ELIGIBLE COALITION via LEAVITT PARTNERS, LLC
2022 · first_quarter · Q1
Source: Senate LDA
| ANTIMICROBIAL RESISTANCE WORKING TABLE (FORMERLY KNOWN AS CONAFAY GROUP) |
| 11 |
| 2018–2020 |
| THE CREATING ACCESS TO REAL-TIME INFORMATION NOW ALLIANCE (CARIN) | 10 | 2017–2020 |
| NATIONAL ALLIANCE TO IMPACT THE SOCIAL DETERMINANTS OF HEALTH | 9 | 2018–2020 |
| THE INDIVIDUAL MARKET COALITION (IMC) | 8 | 2018–2019 |
| BREAKING DOWN BARRIERS TO PAYMENT/DELIVERY SYSTEM REFORM ALLIANCE | 6 | 2018–2019 |
| 510(K) COALITION | 3 | 2014–2017 |
| BAXALTA | 3 | 2015 |
| COALITION FOR DOMESTIC MEDICAL ISOTOPE SUPPLY | 3 | 2014–2015 |
| UNDERWRITERS LABORATORIES (UL) | 1 | 2014 |
Pharmacy and Medically Underserved Areas Enhancement Act
Client: PAPCC COALITION · Firm: LEAVITT PARTNERS, LLC
S.109/H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act
Pharmacy and Medically Underserved Areas Enhancement Act
Client: PAPCC COALITION · Firm: LEAVITT PARTNERS, LLC
S.109/H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act
Pharmacy and Medically Underserved Areas Enhancement Act
Client: PAPCC COALITION · Firm: LEAVITT PARTNERS, LLC
S.109/H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act
Pharmacy and Medically Underserved Areas Enhancement Act
Client: PAPCC COALITION · Firm: LEAVITT PARTNERS, LLC
S.109/H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act
Pharmacy and Medically Underserved Areas Enhancement Act
Client: PAPCC COALITION · Firm: LEAVITT PARTNERS, LLC
S.109/H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act
Pharmacy and Medically Underserved Areas Enhancement Act
Client: PAPCC COALITION · Firm: LEAVITT PARTNERS, LLC
S.109/H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act
Pharmacy and Medically Underserved Areas Enhancement Act
Client: PAPCC COALITION · Firm: LEAVITT PARTNERS, LLC
H.R. 592 - Pharmacy and Medically Undeserved Areas Enhancement Act
Pharmacy and Medically Underserved Areas Enhancement Act
Client: PAPCC COALITION · Firm: LEAVITT PARTNERS, LLC
H.R. 592 - Pharmacy and Medically Undeserved Areas Enhancement Act
Issues related to the Dual Eligible program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL DISTRIBUTION SECURITY ALLIANCE (PDSA) via LEAVITT PARTNERS, LLC
2022 · first_quarter · Q1
Pharmaceutical distribution and supply chain security.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
BAXTER HEALTHCARE via LEAVITT PARTNERS, LLC
2022 · first_quarter · Q1
Pharmaceutical and patient safety issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAXTER HEALTHCARE via LEAVITT PARTNERS, LLC
2021 · fourth_quarter · Q4
​Pharmaceutical and patient safety issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE DUAL ELIGIBLE COALITION via LEAVITT PARTNERS, LLC
2021 · fourth_quarter · Q4
Issues related to the Dual Eligible program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAXTER HEALTHCARE via LEAVITT PARTNERS, LLC
2021 · third_quarter · Q3
​Pharmaceutical and patient safety issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE DUAL ELIGIBLE COALITION via LEAVITT PARTNERS, LLC
2021 · third_quarter · Q3
Issues related to the Dual Eligible program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL DISTRIBUTION SECURITY ALLIANCE (PDSA) via LEAVITT PARTNERS, LLC
2021 · third_quarter · Q3
Pharmaceutical distribution and supply chain security.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
THE DUAL ELIGIBLE COALITION via LEAVITT PARTNERS, LLC
2021 · second_quarter · Q2
Issues related to the Dual Eligible program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL DISTRIBUTION SECURITY ALLIANCE (PDSA) via LEAVITT PARTNERS, LLC
2021 · second_quarter · Q2
Pharmaceutical distribution and supply chain security.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
BAXTER HEALTHCARE via LEAVITT PARTNERS, LLC
2021 · second_quarter · Q2
​Pharmaceutical and patient safety issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE DUAL ELIGIBLE COALITION via LEAVITT PARTNERS, LLC
2021 · first_quarter · Q1
Issues related to the Dual Eligible program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
BAXTER HEALTHCARE via LEAVITT PARTNERS, LLC
2021 · first_quarter · Q1
​Pharmaceutical and patient safety issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL DISTRIBUTION SECURITY ALLIANCE (PDSA) via LEAVITT PARTNERS, LLC
2021 · first_quarter · Q1
Pharmaceutical distribution and supply chain security.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
THE DUAL ELIGIBLE COALITION via LEAVITT PARTNERS, LLC
2020 · fourth_quarter · Q4
Issues related to the Dual Eligible program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
BAXTER HEALTHCARE via LEAVITT PARTNERS, LLC
2020 · fourth_quarter · Q4
Health Care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIAL RESISTANCE WORKING TABLE (FORMERLY KNOWN AS CONAFAY GROUP) via LEAVITT PARTNERS, LLC
2020 · fourth_quarter · 4T
Antimicrobial resistance advocacy and reforms.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
THE DUAL ELIGIBLE COALITION via LEAVITT PARTNERS, LLC
2020 · third_quarter · Q3
Issues related to the Dual Eligible program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
DIAGNOSTIC TEST WORK GROUP (DTWG) via LEAVITT PARTNERS, LLC
2020 · third_quarter · Q3
Medical diagnostic products and services.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIAL RESISTANCE WORKING TABLE (FORMERLY KNOWN AS CONAFAY GROUP) via LEAVITT PARTNERS, LLC
2020 · third_quarter · Q3
Antimicrobial resistance advocacy and reforms.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
BAXTER HEALTHCARE via LEAVITT PARTNERS, LLC
2020 · third_quarter · Q3
Health Care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE CREATING ACCESS TO REAL-TIME INFORMATION NOW ALLIANCE (CARIN) via LEAVITT PARTNERS, LLC
2020 · third_quarter · Q3
​Advancing consumer-directed health information exchange.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA), White House Office
THE CREATING ACCESS TO REAL-TIME INFORMATION NOW ALLIANCE (CARIN) via LEAVITT PARTNERS, LLC
2020 · second_quarter · Q2
​Advancing consumer-directed health information exchange.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA), White House Office
THE DUAL ELIGIBLE COALITION via LEAVITT PARTNERS, LLC
2020 · second_quarter · Q2
Issues related to the Dual Eligible program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
ANTIMICROBIAL RESISTANCE WORKING TABLE (FORMERLY KNOWN AS CONAFAY GROUP) via LEAVITT PARTNERS, LLC
2020 · second_quarter · Q2
Antimicrobial resistance advocacy and reforms.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
DIAGNOSTIC TEST WORK GROUP (DTWG) via LEAVITT PARTNERS, LLC
2020 · second_quarter · Q2
Medical diagnostic products and services.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
BAXTER HEALTHCARE via LEAVITT PARTNERS, LLC
2020 · second_quarter · Q2
Health Care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ALLIANCE TO IMPACT THE SOCIAL DETERMINANTS OF HEALTH via LEAVITT PARTNERS, LLC
2020 · first_quarter · Q1
Social determinants of health interventions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
DIAGNOSTIC TEST WORK GROUP (DTWG) via LEAVITT PARTNERS, LLC
2020 · first_quarter · Q1
Medical diagnostic products and services.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
THE CREATING ACCESS TO REAL-TIME INFORMATION NOW ALLIANCE (CARIN) via LEAVITT PARTNERS, LLC
2020 · first_quarter · Q1
​Advancing consumer-directed health information exchange.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA), White House Office
ANTIMICROBIAL RESISTANCE WORKING TABLE (FORMERLY KNOWN AS CONAFAY GROUP) via LEAVITT PARTNERS, LLC
2020 · first_quarter · Q1
Antimicrobial resistance advocacy and reforms.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
THE DUAL ELIGIBLE COALITION via LEAVITT PARTNERS, LLC
2020 · first_quarter · Q1
Issues related to the Dual Eligible program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
BAXTER HEALTHCARE via LEAVITT PARTNERS, LLC
2020 · first_quarter · Q1
Health Care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL DISTRIBUTION SECURITY ALLIANCE (PDSA) via LEAVITT PARTNERS, LLC
2019 · fourth_quarter · 4A
Pharmaceutical distribution and supply chain security.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PHARMACEUTICAL DISTRIBUTION SECURITY ALLIANCE (PDSA) via LEAVITT PARTNERS, LLC
2019 · fourth_quarter · 4A
Pharmaceutical distribution and supply chain security.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
THE CREATING ACCESS TO REAL-TIME INFORMATION NOW ALLIANCE (CARIN) via LEAVITT PARTNERS, LLC
2019 · fourth_quarter · Q4
​Advancing consumer-directed health information exchange.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA), White House Office
PHARMACEUTICAL DISTRIBUTION SECURITY ALLIANCE (PDSA) via LEAVITT PARTNERS, LLC
2019 · fourth_quarter · Q4
Pharmaceutical distribution and supply chain security.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
THE DUAL ELIGIBLE COALITION via LEAVITT PARTNERS, LLC
2019 · fourth_quarter · Q4
Issues related to the Dual Eligible program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
NATIONAL ALLIANCE TO IMPACT THE SOCIAL DETERMINANTS OF HEALTH via LEAVITT PARTNERS, LLC
2019 · fourth_quarter · Q4
Social determinants of health interventions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ANTIMICROBIAL RESISTANCE WORKING TABLE (FORMERLY KNOWN AS CONAFAY GROUP) via LEAVITT PARTNERS, LLC
2019 · fourth_quarter · Q4
Antimicrobial resistance advocacy and reforms.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
DIAGNOSTIC TEST WORK GROUP (DTWG) via LEAVITT PARTNERS, LLC
2019 · fourth_quarter · Q4
Medical diagnostic products and services.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
BAXTER HEALTHCARE via LEAVITT PARTNERS, LLC
2019 · fourth_quarter · Q4
Health Care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKING DOWN BARRIERS TO PAYMENT/DELIVERY SYSTEM REFORM ALLIANCE via LEAVITT PARTNERS, LLC
2019 · fourth_quarter · Q4
The Alliance is working to develop consensus proposals to modify the Stark Act, Anti-Kickback Statute (AKS), False Claims Act, and other laws or regulations to establish an environment that encourages value-based arrangements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ALLIANCE TO IMPACT THE SOCIAL DETERMINANTS OF HEALTH via LEAVITT PARTNERS, LLC
2019 · third_quarter · Q3
Social determinants of health interventions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
THE DUAL ELIGIBLE COALITION via LEAVITT PARTNERS, LLC
2019 · third_quarter · Q3
Issues related to the Dual Eligible program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
PHARMACEUTICAL DISTRIBUTION SECURITY ALLIANCE (PDSA) via LEAVITT PARTNERS, LLC
2019 · third_quarter · Q3
Pharmaceutical distribution and supply chain security.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
DIAGNOSTIC TEST WORK GROUP (DTWG) via LEAVITT PARTNERS, LLC
2019 · third_quarter · Q3
Medical diagnostic products and services.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
DDUSA via LEAVITT PARTNERS, LLC
2019 · third_quarter · Q3
Health Care and device distribution licensing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE CREATING ACCESS TO REAL-TIME INFORMATION NOW ALLIANCE (CARIN) via LEAVITT PARTNERS, LLC
2019 · third_quarter · Q3
​Advancing consumer-directed health information exchange.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
BAXTER HEALTHCARE via LEAVITT PARTNERS, LLC
2019 · third_quarter · Q3
Health Care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTIMICROBIAL RESISTANCE WORKING TABLE (FORMERLY KNOWN AS CONAFAY GROUP) via LEAVITT PARTNERS, LLC
2019 · third_quarter · Q3
Antimicrobial resistance advocacy and reforms.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
NATIONAL ALLIANCE TO IMPACT THE SOCIAL DETERMINANTS OF HEALTH via LEAVITT PARTNERS, LLC
2019 · second_quarter · Q2
Social determinants of health interventions.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
BREAKING DOWN BARRIERS TO PAYMENT/DELIVERY SYSTEM REFORM ALLIANCE via LEAVITT PARTNERS, LLC
2019 · second_quarter · Q2
The Alliance is working to develop consensus proposals to modify the Stark Act, Anti-Kickback Statute (AKS), False Claims Act, and other laws or regulations to establish an environment that encourages value-based arrangements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE DUAL ELIGIBLE COALITION via LEAVITT PARTNERS, LLC
2019 · second_quarter · Q2
Issues related to the Dual Eligible program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
ANTIMICROBIAL RESISTANCE WORKING TABLE (FORMERLY KNOWN AS CONAFAY GROUP) via LEAVITT PARTNERS, LLC
2019 · second_quarter · Q2
Antimicrobial resistance advocacy and reforms.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
THE INDIVIDUAL MARKET COALITION (IMC) via LEAVITT PARTNERS, LLC
2019 · second_quarter · 2T
Issues related to the individual health insurance market.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE INDIVIDUAL MARKET COALITION (IMC) via LEAVITT PARTNERS, LLC
2019 · second_quarter · Q2
Issues related to the individual health insurance market.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DIAGNOSTIC TEST WORK GROUP (DTWG) via LEAVITT PARTNERS, LLC
2019 · second_quarter · Q2
Medical diagnostic products and services.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
BAXTER HEALTHCARE via LEAVITT PARTNERS, LLC
2019 · second_quarter · Q2
Health Care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ALLIANCE TO IMPACT THE SOCIAL DETERMINANTS OF HEALTH via LEAVITT PARTNERS, LLC
2019 · first_quarter · Q1
Social determinants of health interventions.
Filing targets: Health & Human Services, Dept of (HHS), SENATE, White House Office
THE INDIVIDUAL MARKET COALITION (IMC) via LEAVITT PARTNERS, LLC
2019 · first_quarter · Q1
Issues related to the individual health insurance market.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ANTIMICROBIAL RESISTANCE WORKING TABLE (FORMERLY KNOWN AS CONAFAY GROUP) via LEAVITT PARTNERS, LLC
2019 · first_quarter · Q1
Antimicrobial resistance advocacy and reforms.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
THE DUAL ELIGIBLE COALITION via LEAVITT PARTNERS, LLC
2019 · first_quarter · Q1
Issues related to the Dual Eligible program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
BREAKING DOWN BARRIERS TO PAYMENT/DELIVERY SYSTEM REFORM ALLIANCE via LEAVITT PARTNERS, LLC
2019 · first_quarter · Q1
The Alliance is working to develop consensus proposals to modify the Stark Act, Anti-Kickback Statute (AKS), False Claims Act, and other laws or regulations to establish an environment that encourages value-based arrangements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE CREATING ACCESS TO REAL-TIME INFORMATION NOW ALLIANCE (CARIN) via LEAVITT PARTNERS, LLC
2019 · first_quarter · Q1
​Advancing consumer-directed health information exchange.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
DIAGNOSTIC TEST WORK GROUP (DTWG) via LEAVITT PARTNERS, LLC
2019 · first_quarter · Q1
Medical diagnostic products and services.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
BAXTER HEALTHCARE via LEAVITT PARTNERS, LLC
2019 · first_quarter · Q1
Health Care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DDUSA via LEAVITT PARTNERS, LLC
2019 · first_quarter · Q1
Health Care and device distribution licensing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ALLIANCE TO IMPACT THE SOCIAL DETERMINANTS OF HEALTH via LEAVITT PARTNERS, LLC
2018 · fourth_quarter · 4A
Social determinants of health interventions.
ANTIMICROBIAL RESISTANCE WORKING TABLE (FORMERLY KNOWN AS CONAFAY GROUP) via LEAVITT PARTNERS, LLC
2018 · fourth_quarter · 4A
Antimicrobial resistance advocacy and reforms.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
BREAKING DOWN BARRIERS TO PAYMENT/DELIVERY SYSTEM REFORM ALLIANCE via LEAVITT PARTNERS, LLC
2018 · fourth_quarter · Q4
The Alliance is working to develop consensus proposals to modify the Stark Act, Anti-Kickback Statute (AKS), False Claims Act, and other laws or regulations to establish an environment that encourages value-based arrangements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE INDIVIDUAL MARKET COALITION (IMC) via LEAVITT PARTNERS, LLC
2018 · fourth_quarter · Q4
Issues related to the individual health insurance market.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE DUAL ELIGIBLE COALITION via LEAVITT PARTNERS, LLC
2018 · fourth_quarter · Q4
Issues related to the Dual Eligible program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
THE CREATING ACCESS TO REAL-TIME INFORMATION NOW ALLIANCE (CARIN) via LEAVITT PARTNERS, LLC
2018 · fourth_quarter · Q4
Advancing consumer-directed health information exchange.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ALLIANCE TO IMPACT THE SOCIAL DETERMINANTS OF HEALTH via LEAVITT PARTNERS, LLC
2018 · fourth_quarter · Q4
Social determinants of health interventions.
Filing targets: Health & Human Services, Dept of (HHS), SENATE, White House Office
PAPCC COALITION via LEAVITT PARTNERS, LLC
2018 · fourth_quarter · Q4
S.109/H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIAGNOSTIC TEST WORK GROUP (DTWG) via LEAVITT PARTNERS, LLC
2018 · fourth_quarter · Q4
Medical diagnostic products and services.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
BAXTER HEALTHCARE via LEAVITT PARTNERS, LLC
2018 · fourth_quarter · Q4
Health Care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ALLIANCE TO IMPACT THE SOCIAL DETERMINANTS OF HEALTH via LEAVITT PARTNERS, LLC
2018 · third_quarter · Q3
Social determinants of health interventions.
Filing targets: Health & Human Services, Dept of (HHS), SENATE, White House Office
NATIONAL ALLIANCE TO IMPACT THE SOCIAL DETERMINANTS OF HEALTH via LEAVITT PARTNERS, LLC
2018 · third_quarter · RR
Social determinants of health interventions.
ANTIMICROBIAL RESISTANCE WORKING TABLE (FORMERLY KNOWN AS CONAFAY GROUP) via LEAVITT PARTNERS, LLC
2018 · third_quarter · Q3
Antimicrobial resistance advocacy and reforms.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
THE DUAL ELIGIBLE COALITION via LEAVITT PARTNERS, LLC
2018 · third_quarter · Q3
Issues related to the Dual Eligible program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
DIAGNOSTIC TEST WORK GROUP (DTWG) via LEAVITT PARTNERS, LLC
2018 · third_quarter · Q3
Medical diagnostic products and services.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
THE DUAL ELIGIBLE COALITION via LEAVITT PARTNERS, LLC
2018 · third_quarter · RR
Issues related to the Dual Eligible program.
PAPCC COALITION via LEAVITT PARTNERS, LLC
2018 · third_quarter · Q3
S.109/H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE INDIVIDUAL MARKET COALITION (IMC) via LEAVITT PARTNERS, LLC
2018 · third_quarter · Q3
Issues related to the individual health insurance market.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ANTIMICROBIAL RESISTANCE WORKING TABLE (FORMERLY KNOWN AS CONAFAY GROUP) via LEAVITT PARTNERS, LLC
2018 · third_quarter · RR
Antimicrobial resistance advocacy and reforms.
THE CREATING ACCESS TO REAL-TIME INFORMATION NOW ALLIANCE (CARIN) via LEAVITT PARTNERS, LLC
2018 · third_quarter · Q3
Advancing consumer-directed health information exchange.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAXTER HEALTHCARE via LEAVITT PARTNERS, LLC
2018 · third_quarter · Q3
Health Care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PAPCC COALITION via LEAVITT PARTNERS, LLC
2018 · second_quarter · Q2
S.109/H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE INDIVIDUAL MARKET COALITION (IMC) via LEAVITT PARTNERS, LLC
2018 · second_quarter · Q2
Issues related to the individual health insurance market.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BREAKING DOWN BARRIERS TO PAYMENT/DELIVERY SYSTEM REFORM ALLIANCE via LEAVITT PARTNERS, LLC
2018 · second_quarter · Q2
Providers, payers, patient groups, device/pharmaceutical manufacturers coalition advocacy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL DISTRIBUTION SECURITY ALLIANCE (PDSA) via LEAVITT PARTNERS, LLC
2018 · second_quarter · Q2
Pharmaceutical distribution and supply chain security
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
DIAGNOSTIC TEST WORK GROUP (DTWG) via LEAVITT PARTNERS, LLC
2018 · second_quarter · Q2
Medical diagnostic products and services.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
BAXTER HEALTHCARE via LEAVITT PARTNERS, LLC
2018 · second_quarter · Q2
Health Care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE CREATING ACCESS TO REAL-TIME INFORMATION NOW ALLIANCE (CARIN) via LEAVITT PARTNERS, LLC
2018 · first_quarter · Q1
Health care digital health information legislation and oversight.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PAPCC COALITION via LEAVITT PARTNERS, LLC
2018 · first_quarter · Q1
S.109/H.R. 592 - Pharmacy and Medically Underserved Areas Enhancement Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKING DOWN BARRIERS TO PAYMENT/DELIVERY SYSTEM REFORM ALLIANCE via LEAVITT PARTNERS, LLC
2018 · first_quarter · RR
The Alliance is working to develop consensus proposals to modify the Stark Act, Anti-Kickback Statute (AKS), False Claims Act, and other laws or regulations to establish an environment that encourages value-based arrangements.
THE INDIVIDUAL MARKET COALITION (IMC) via LEAVITT PARTNERS, LLC
2018 · first_quarter · Q1
The individual health insurance market.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE